Index -
P/E -
EPS (ttm) -0.56
Insider Own 1.09%
Shs Outstand 47.18M
Perf Week 0.51%
Market Cap 3.04B
Forward P/E 12.06
EPS next Y 5.35
Insider Trans 5.64%
Shs Float 46.67M
Perf Month -8.36%
Income -15.00M
PEG -
EPS next Q 1.20
Inst Own 94.68%
Short Float 2.94%
Perf Quarter -23.96%
Sales 2.05B
P/S 1.49
EPS this Y -1.76%
Inst Trans -4.49%
Short Ratio 2.51
Perf Half Y -27.41%
Book/sh 54.94
P/B 1.17
EPS next Y 22.32%
ROA 0.09%
Short Interest 1.37M
Perf Year -29.56%
Cash/sh 6.19
P/C 10.42
EPS next 5Y 11.60%
ROE 0.18%
52W Range 60.60 - 102.50
Perf YTD -9.74%
Dividend Est. 1.69 (2.63%)
P/FCF 28.44
EPS past 5Y -15.86%
ROI -0.38%
52W High -37.07%
Beta 0.88
Dividend TTM 1.60 (2.48%)
Quick Ratio 1.27
Sales past 5Y -2.62%
Gross Margin 25.12%
52W Low 6.43%
ATR (14) 2.26
Dividend Ex-Date Feb 28, 2025
Current Ratio 2.52
EPS Y/Y TTM -115.63%
Oper. Margin 7.38%
RSI (14) 36.89
Volatility 5.61% 3.00%
Employees 3200
Debt/Eq 0.55
Sales Y/Y TTM -4.35%
Profit Margin -0.73%
Recom 1.55
Target Price 86.10
Option/Short Yes / Yes
LT Debt/Eq 0.54
EPS Q/Q -717.41%
Payout 46.75%
Rel Volume 0.88
Prev Close 64.44
Sales Surprise -5.61%
EPS Surprise 65.00%
Sales Q/Q -14.38%
Earnings Jan 28 AMC
Avg Volume 545.55K
Price 64.50
SMA20 -5.96%
SMA50 -10.71%
SMA200 -25.12%
Trades
Volume 103,081
Change 0.09%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-08-24 Upgrade
JP Morgan
Underweight → Neutral
$90 → $89
Apr-11-24 Upgrade
Wells Fargo
Equal Weight → Overweight
$100 → $112
Mar-14-24 Upgrade
Jefferies
Hold → Buy
$100 → $126
Mar-01-24 Initiated
Wolfe Research
Outperform
$108
Jun-29-23 Downgrade
Evercore ISI
Outperform → In-line
Jun-26-23 Downgrade
BMO Capital Markets
Outperform → Market Perform
$109 → $90
Feb-02-23 Downgrade
JP Morgan
Neutral → Underweight
$104 → $105
Sep-12-22 Initiated
Credit Suisse
Outperform
$120
Jan-20-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$120 → $110
Nov-11-21 Downgrade
Monness Crespi & Hardt
Buy → Neutral
Oct-13-21 Initiated
Mizuho
Buy
$116
Jul-30-21 Upgrade
JP Morgan
Underweight → Neutral
$90
Jun-18-21 Initiated
Stifel
Buy
$118
May-04-21 Downgrade
JP Morgan
Neutral → Underweight
$88 → $89
Mar-15-21 Resumed
Credit Suisse
Outperform
$103
Feb-05-21 Reiterated
Monness Crespi & Hardt
Buy
$88 → $100
Sep-22-20 Initiated
Evercore ISI
In-line
Jul-30-20 Reiterated
Monness Crespi & Hardt
Buy
$80 → $88
May-07-20 Upgrade
JP Morgan
Underweight → Neutral
$68 → $62
Apr-17-20 Reiterated
Monness Crespi & Hardt
Buy
$88 → $80
Show Previous Ratings
Jan-31-25 02:17AM
Jan-30-25 03:10AM
(Thomson Reuters StreetEvents)
Jan-28-25 05:23PM
(Associated Press Finance)
-9.82%
05:01PM
07:08AM
07:04AM
Loading…
Jan-27-25 07:04AM
Jan-20-25 05:00PM
01:09PM
Jan-16-25 07:09AM
Jan-14-25 07:00AM
Dec-23-24 05:01PM
Dec-16-24 04:15PM
Dec-09-24 05:01PM
06:30AM
Nov-21-24 01:00AM
07:00AM
Loading…
Nov-14-24 07:00AM
Nov-08-24 07:00AM
02:16AM
Nov-06-24 07:15PM
06:27PM
(Associated Press Finance)
05:00PM
07:09AM
Nov-05-24 09:15AM
07:40AM
Oct-31-24 12:22PM
Oct-28-24 05:00PM
Oct-09-24 10:40AM
Oct-07-24 07:31AM
Sep-19-24 10:06AM
Sep-16-24 07:00AM
07:00AM
Loading…
Sep-03-24 07:00AM
07:00AM
07:00AM
Sep-01-24 10:04PM
Aug-28-24 08:04PM
Aug-25-24 01:53PM
(The Wall Street Journal)
Aug-23-24 09:40AM
Aug-09-24 05:01PM
Aug-07-24 09:40AM
06:55AM
Aug-06-24 05:31PM
(Associated Press Finance)
05:01PM
Aug-05-24 09:40AM
Jul-25-24 04:39PM
Jul-17-24 07:00AM
Jun-24-24 07:00AM
Jun-18-24 07:00AM
Jun-04-24 08:00AM
May-30-24 11:31AM
May-17-24 09:25AM
May-09-24 11:03AM
May-08-24 05:01PM
09:50AM
May-07-24 05:01PM
07:00AM
06:59AM
May-06-24 09:40AM
May-02-24 04:02PM
08:45AM
03:17AM
May-01-24 04:52PM
Apr-30-24 09:53PM
06:32PM
05:13PM
(Associated Press Finance)
05:01PM
Apr-18-24 06:59AM
Apr-15-24 06:59AM
Apr-11-24 11:13AM
Apr-03-24 05:01PM
Mar-28-24 04:05PM
Mar-08-24 06:59AM
Feb-29-24 11:30AM
Feb-06-24 12:20PM
Feb-01-24 10:12AM
01:20AM
(Thomson Reuters StreetEvents)
Jan-31-24 07:17PM
10:54AM
Jan-30-24 07:00PM
05:42PM
05:11PM
(Associated Press Finance)
05:01PM
Jan-29-24 09:16AM
Jan-22-24 05:01PM
Jan-16-24 05:00PM
Jan-09-24 07:00AM
Dec-08-23 11:30AM
Dec-04-23 07:00AM
Nov-30-23 07:00AM
Nov-23-23 01:04PM
Nov-21-23 12:20PM
07:00AM
Nov-14-23 05:25PM
Nov-13-23 05:00PM
Nov-09-23 06:55AM
Nov-08-23 07:55PM
(Associated Press Finance)
05:58PM
05:00PM
Nov-01-23 05:00PM
Oct-26-23 06:01AM
Oct-25-23 06:23AM
Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
NOVO GUILLERMO Chair of the Board and CEO Jan 31 '25 Buy 64.24 31,294 2,010,327 31,294 Feb 03 04:30 PM Assis Alessandra Faccin SVP and GM, Life Sciences Jan 31 '25 Buy 64.00 3,150 201,600 3,150 Feb 03 04:30 PM Harrison Suzan F. Director Jan 23 '25 Option Exercise 0.00 1,931 0 1,931 Jan 24 04:30 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Dec 05 '24 Sale 78.07 451 35,210 14,182 Dec 09 05:15 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Dec 04 '24 Option Exercise 59.95 451 27,037 14,633 Dec 05 05:00 PM BONI ERIC N Officer Dec 05 '24 Proposed Sale 78.07 451 35,210 Dec 05 09:53 AM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 19 '24 Option Exercise 76.39 418 31,931 3,641 Nov 20 04:30 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 19 '24 Sale 75.54 162 12,237 3,354 Nov 20 04:30 PM MUSA OSAMA M SVP and CTO Nov 19 '24 Option Exercise 76.39 1,878 143,460 27,288 Nov 20 04:30 PM BOSTAPH KARL R. Senior VP Operations Nov 19 '24 Option Exercise 76.39 418 31,931 7,165 Nov 20 04:30 PM Drury Eileen SVP and Chief HRO Nov 19 '24 Option Exercise 76.39 911 69,591 6,606 Nov 20 04:30 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 19 '24 Option Exercise 76.39 450 34,376 14,312 Nov 20 04:30 PM WILLIS J KEVIN SVP and CFO Nov 19 '24 Option Exercise 76.39 3,486 266,296 234,324 Nov 20 04:30 PM NOVO GUILLERMO Chair of the Board and CEO Nov 19 '24 Option Exercise 76.39 11,096 847,623 131,382 Nov 20 04:30 PM WILLIS J KEVIN SVP and CFO Nov 18 '24 Option Exercise 77.03 3,860 297,336 231,649 Nov 19 05:06 PM NOVO GUILLERMO Chair of the Board and CEO Nov 18 '24 Option Exercise 77.03 12,639 973,582 122,778 Nov 19 04:42 PM Drury Eileen SVP and Chief HRO Nov 18 '24 Option Exercise 77.03 1,101 84,810 5,956 Nov 19 04:42 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 18 '24 Option Exercise 77.03 486 37,437 3,293 Nov 19 04:41 PM MUSA OSAMA M SVP and CTO Nov 18 '24 Option Exercise 77.03 2,081 160,299 25,751 Nov 19 04:41 PM BOSTAPH KARL R. Senior VP Operations Nov 18 '24 Option Exercise 77.03 638 49,145 6,888 Nov 19 04:40 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 18 '24 Option Exercise 77.03 510 39,285 13,931 Nov 19 04:39 PM LAMPKIN ROBIN E. Officer Nov 19 '24 Proposed Sale 75.54 162 12,237 Nov 19 10:12 AM MUSA OSAMA M SVP and CTO Nov 14 '24 Option Exercise 78.05 2,031 158,520 24,776 Nov 18 05:36 PM BOSTAPH KARL R. Senior VP Operations Nov 14 '24 Option Exercise 78.05 1,054 82,265 6,728 Nov 18 05:35 PM Drury Eileen SVP and Chief HRO Nov 14 '24 Option Exercise 78.05 1,258 98,187 5,711 Nov 18 05:34 PM WILLIS J KEVIN SVP and CFO Nov 14 '24 Option Exercise 78.05 3,771 294,327 230,497 Nov 18 05:34 PM NOVO GUILLERMO Chair of the Board and CEO Nov 14 '24 Option Exercise 78.05 8,865 691,913 116,649 Nov 18 05:33 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 14 '24 Option Exercise 78.05 1,238 96,626 4,121 Nov 18 05:33 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Nov 15 '24 Sale 77.90 868 67,617 2,883 Nov 18 05:33 PM MINICUCCI JAMES P. SVP and GM, Personal Care Nov 14 '24 Option Exercise 78.05 1,190 92,880 2,126 Nov 18 05:32 PM BONI ERIC N VP, Finance & Prinpl Acctg Off Nov 14 '24 Option Exercise 78.05 602 46,986 13,674 Nov 18 05:31 PM LAMPKIN ROBIN E. Officer Nov 15 '24 Proposed Sale 77.90 868 67,617 Nov 15 01:19 PM WILLIS J KEVIN SVP and CFO Sep 03 '24 Option Exercise 59.95 5,487 328,946 22,539 Sep 05 04:30 PM WILLIS J KEVIN SVP and CFO Sep 04 '24 Sale 87.88 5,487 482,198 17,052 Sep 05 04:30 PM WILLIS J KEVIN Officer Sep 04 '24 Proposed Sale 87.88 5,487 482,198 Sep 04 11:14 AM MINICUCCI JAMES P. SVP and GM, Personal Care May 08 '24 Option Exercise 97.56 1,364 133,072 1,364 May 20 04:15 PM MUSA OSAMA M SVP and CTO May 08 '24 Option Exercise 59.56 9,698 577,632 27,861 May 09 07:37 PM LAMPKIN ROBIN E. SVP, Gen Counsel and Secrty. Feb 16 '24 Sale 92.54 844 78,104 2,883 Feb 20 04:15 PM
Index RUT
P/E 29.65
EPS (ttm) 3.92
Insider Own 8.71%
Shs Outstand 20.77M
Perf Week 0.04%
Market Cap 2.43B
Forward P/E 27.26
EPS next Y 4.26
Insider Trans 0.00%
Shs Float 19.11M
Perf Month -5.54%
Income 81.85M
PEG -
EPS next Q 0.70
Inst Own 68.86%
Short Float 2.81%
Perf Quarter 9.17%
Sales 952.13M
P/S 2.55
EPS this Y 10.28%
Inst Trans 0.45%
Short Ratio 3.86
Perf Half Y 1.32%
Book/sh 22.01
P/B 5.28
EPS next Y 7.63%
ROA 12.11%
Short Interest 0.54M
Perf Year 89.89%
Cash/sh 0.40
P/C 292.89
EPS next 5Y -
ROE 19.24%
52W Range 58.26 - 139.55
Perf YTD -5.31%
Dividend Est. -
P/FCF 30.30
EPS past 5Y 25.79%
ROI 14.32%
52W High -16.77%
Beta 0.75
Dividend TTM 0.86 (0.74%)
Quick Ratio 1.53
Sales past 5Y 11.28%
Gross Margin 22.98%
52W Low 99.37%
ATR (14) 5.03
Dividend Ex-Date Feb 14, 2025
Current Ratio 2.50
EPS Y/Y TTM 12.36%
Oper. Margin 12.08%
RSI (14) 49.68
Volatility 6.49% 4.44%
Employees 934
Debt/Eq 0.27
Sales Y/Y TTM 3.01%
Profit Margin 8.60%
Recom 3.00
Target Price 122.00
Option/Short Yes / Yes
LT Debt/Eq 0.25
EPS Q/Q 1.07%
Payout 17.85%
Rel Volume 0.86
Prev Close 115.98
Sales Surprise 4.00%
EPS Surprise 14.65%
Sales Q/Q 8.49%
Earnings Jan 29 AMC
Avg Volume 139.27K
Price 116.15
SMA20 2.18%
SMA50 -5.54%
SMA200 5.36%
Trades
Volume 25,703
Change 0.15%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-16-24 Downgrade
BWS Financial
Buy → Neutral
Aug-07-23 Upgrade
BWS Financial
Neutral → Buy
$62
Feb-03-25 01:14PM
09:05AM
Jan-30-25 04:18PM
Jan-29-25 05:25PM
04:18PM
(Associated Press Finance)
04:10PM
Loading…
04:10PM
04:05PM
Jan-15-25 09:05AM
Nov-30-24 01:37PM
Nov-04-24 11:23AM
Nov-01-24 09:35AM
Oct-30-24 04:57PM
(Associated Press Finance)
-8.86%
04:10PM
04:05PM
09:05AM
12:00PM
Loading…
Oct-22-24 12:00PM
Oct-21-24 12:45PM
Oct-16-24 09:05AM
Sep-29-24 06:37AM
Aug-28-24 12:45PM
Aug-23-24 11:02AM
09:40AM
Aug-19-24 11:47AM
Aug-12-24 12:45PM
Aug-08-24 08:00AM
Aug-06-24 12:20PM
Jul-31-24 05:45PM
04:44PM
(Associated Press Finance)
04:10PM
04:05PM
09:05AM
Loading…
Jul-17-24 09:05AM
Jul-15-24 09:05AM
Jul-10-24 04:45PM
Jul-08-24 11:26AM
Jul-01-24 09:05AM
Jun-20-24 07:59AM
07:59AM
Jun-15-24 02:50AM
Jun-13-24 02:44AM
Jun-11-24 01:28AM
Jun-07-24 02:37AM
Jun-04-24 10:18AM
Jun-03-24 09:05AM
May-30-24 08:34AM
May-16-24 08:12AM
May-15-24 08:53PM
05:03PM
(Associated Press Finance)
04:36PM
04:10PM
04:05PM
May-13-24 09:05AM
May-01-24 09:05AM
Apr-08-24 09:28AM
Mar-21-24 11:48AM
10:41AM
Mar-14-24 09:15AM
Mar-13-24 11:54AM
Mar-12-24 10:30AM
07:07AM
Mar-11-24 09:05AM
Mar-06-24 08:00AM
Mar-05-24 09:40AM
Feb-27-24 12:45PM
Feb-21-24 09:05AM
Feb-16-24 09:05AM
Feb-15-24 08:00AM
Feb-12-24 08:26AM
Feb-05-24 12:00PM
Feb-01-24 01:04PM
12:36PM
Jan-31-24 04:24PM
(Associated Press Finance)
04:10PM
04:05PM
Jan-25-24 07:53AM
Jan-17-24 04:05PM
Dec-28-23 01:01PM
Dec-07-23 03:08PM
09:15AM
Nov-30-23 09:40AM
Nov-27-23 11:08AM
Nov-22-23 11:26AM
Nov-15-23 09:15AM
Nov-07-23 06:59AM
Nov-01-23 05:43PM
(Associated Press Finance)
-5.03%
04:10PM
04:05PM
Oct-30-23 09:05AM
Oct-20-23 04:32AM
Oct-19-23 08:15AM
Oct-18-23 09:05AM
Oct-06-23 06:09AM
Oct-05-23 12:45PM
07:58AM
06:42AM
06:39AM
Oct-04-23 12:47PM
11:28AM
08:16AM
Oct-03-23 09:48AM
07:34AM
Hawkins, Inc. engages in the distribution, blending, and manufacture of chemicals and specialty ingredients for a wide variety of industries. It operates through the following segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment provides industrial chemicals, products, and services to the agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal, industrial wastewater, industrial process water, and non-residential swimming pool water. The Health and Nutrition segment consists of ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, health, and wellness products. The company was founded by Howard Hawkins in 1938 and is headquartered in Roseville, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Faulconbridge James A Director Jun 12 '24 Buy 89.94 1,800 161,899 47,817 Jun 14 04:09 PM Faulconbridge James A Director Jun 11 '24 Buy 89.05 2,000 178,099 46,017 Jun 12 06:02 PM Faulconbridge James A Director Jun 10 '24 Buy 86.47 2,000 172,937 44,017 Jun 12 06:02 PM Faulconbridge James A Director Jun 06 '24 Buy 87.56 1,800 157,613 40,517 Jun 10 04:27 PM Faulconbridge James A Director Jun 07 '24 Buy 87.53 1,500 131,294 42,017 Jun 10 04:27 PM Faulconbridge James A Director Jun 04 '24 Buy 86.50 1,300 112,454 38,117 Jun 06 04:33 PM Faulconbridge James A Director Jun 05 '24 Buy 86.57 600 51,942 38,717 Jun 06 04:33 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite